Curi Bio provides human stem cell-based platforms for drug discovery and tissue engineering applications. Their products and services aim to bridge the gap between in vitro and in vivo testing by providing more physiologically relevant human cell models. This enables researchers to predict human outcomes better, accelerating the development of new therapies.
Visit Company Website
